Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Journal of Biomolecular Structure & Dynamics|February 20, 2020
Atomic-scale modeling of the effect of lipid peroxidation on the permeability of reactive speciesSurendra Kumar, Rashmi Rana, Dharmendra K YadavCurrent Topics in Medicinal Chemistry|April 13, 2019
Recent Developments in Natural Product Inspired Synthetic 1,2,4- Trioxolanes (Ozonides): An Unusual Entry into Antimalarial ChemotherapyMohit K Tiwari, Dharmendra K Yadav, Sandeep ChaudharyBiochemical and Biophysical Research Communications|July 15, 2025
In silico investigations of natural-product tethered 1,4-naphthoquinones as inhibitors of StaphylococcusaureusSatyam Srivastava, Harish C Upadhyay, Dharmendra K YadavAAPS Pharmscitech|January 14, 2015
Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approachDharmendra K Yadav, Harish Pawar, Shrikant Wankhade, et al.Pharmaceutical Development and Technology|September 3, 2015
Development and evaluation of co-formulated docetaxel and curcumin biodegradable nanoparticles for parenteral administrationHarish Pawar, Shrikant Rameshrao Wankhade, Dharmendra K Yadav, et al.Journal of Cheminformatics|November 1, 2017
The comparison of automated clustering algorithms for resampling representative conformer ensembles with RMSD matrixHyoungrae Kim, Cheongyun Jang, Dharmendra K Yadav, et al.Frontiers in Cellular and Infection Microbiology|March 3, 2022
SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based TherapyDesh Deepak Singh, Anshul Sharma, Hae-Jeung Lee, et al.Fitoterapia|March 8, 2020
Microwave-assisted modified synthesis of C8-analogues of naturally occurring methylxanthines: Synthesis, biological evaluation and their practical applicationsBharti Rajesh Kumar Shyamlal, Manas Mathur, Dharmendra K Yadav, et al.Frontiers in Cell and Developmental Biology|November 26, 2020
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2Desh Deepak Singh, Ihn Han, Eun-Ha Choi, et al.Current Pharmaceutical Design|June 8, 2012
QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparumTabish Qidwai, Dharmendra K Yadav, Feroz Khan, et al.Pageof 6